On October 8, THE CIGNA GROUP rose 3.02% in regular trading, trading at $282.13/share, with Turnover of $173 million.
The upward move followed its Investor Day, where management set long-term financial targets through 2030. Bernstein raised its price target to $387 from $381 and maintained an Outperform rating. RBC Capital Markets said the company is better positioned to achieve its long-term EPS growth goals, citing management's reaffirmed 10% to 14% adjusted EPS CAGR and 2030 adjusted EPS of at least $45.
Jefferies, however, lowered its target to $288 from $307 while keeping a Hold rating.
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment offers pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery solutions, while its Cigna Healthcare segment provides medical, pharmacy, behavioral health, dental, and other products for insured and self-insured customers.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)